Efficacy & mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D)
21st August 2015
Body: EME
Amount: £725,000
People
| Photo | Name | Bio |
|---|---|---|
 |
Professor Robin Spiller | Professor Spiller is Professor of Gastroenterology in the NIHR Nottingham Biomedical Research Centre at the University of Nottingham. Past Editor of Gut (2003-2009) and member of the Board of the Rome Foundation (2000-2015), he twice edited the… |
